Immunohistochemical staining of Anaplastic Lymphoma Kinase  of human FFPE tissue followed by incubation with HRP labeled secondary and development with DAB substrate.

Anaplastic Lymphoma Kinase [4A4] Antibody (cGMP).

$ 128.00$ 468.00
Please Select Product Options Below To View The Catalog Number.

SKU: QIVD67
Species: Human
Tested Applications: IHC [IVD]
Available Conjugates:
Isotype: Mouse IgG2b

Product NumberDescriptionPrice
QIVD67-0.1ml Size: 0.1 ml, Format: Concentrate $ 128.00
QIVD67-0.5ml Size: 0.5 ml, Format: Concentrate $ 278.00
QIVD67-1ml Size: 1 ml, Format: Concentrate $ 468.00
QIVD67-6ml Size: 6 ml, Format: Predilute $ 358.00
Shipping Information
In Stock
Flat Rate Shipping Anywhere in the US: $45
Datasheets and Documentation
Product Datasheet
Certificate of Analysis and Tags (Coming Soon)
Lot Number:

Expiration Date:

Concentration (Write Lyophilized if Lyophilized):

Reconsitution Instructions (Leave Blank if Liquid):

Manufacture Date:

Purity:

Bioactivity (test results eg. IU/ml):


SKU: QIVD67-0.1ml
Anaplastic Lymphoma Kinase General Information
Alternate Names
Molecular Weight
176.4 kDa
Chromosomal Location
p23.1 [chr: 2] [chr_start: 29192774] [chr_end: 29921586] [strand: -1]
Curated Database and Bioinformatic Data
Gene SymbolALK
Entrez Gene ID238
RefSeq Protein Accession(s)NP_004295
RefSeq mRNA Accession(s)XM_024452779; NM_001353765; XR_001738688; XM_024452778; NM_004304
RefSeq Genomic Accession(s)NC_000002; NG_009445
UniProt ID(s)Q9UM73
PharmGKB ID(s)PA24719
KEGG Gene ID(s)hsa:238
Associated Diseases (KEGG IDs)A chromosomal aberration involving ALK is found in a form of non-Hodgkin lymphoma. Translocation t(2;5)(p23;q35) with NPM1. The resulting chimeric NPM1-ALK protein homodimerize and the kinase becomes constitutively activated. The constitutively active fusion proteins are responsible for 5-10% of non-Hodgkin lymphomas.; A chromosomal aberration involving ALK is associated with inflammatory myofibroblastic tumors (IMTs). Translocation t(2;11)(p23;p15) with CARS; translocation t(2;4)(p23;q21) with SEC31A.; A chromosomal aberration involving ALK is associated with anaplastic large-cell lymphoma (ALCL). Translocation t(2;17)(p23;q25) with ALO17.; Neuroblastoma 3 (NBLST3) [MIM:613014]: A common neoplasm of early childhood arising from embryonic cells that form the primitive neural crest and give rise to the adrenal medulla and the sympathetic nervous system. {ECO:0000269|PubMed:18724359, ECO:0000269|PubMed:18923523, ECO:0000269|PubMed:18923525, ECO:0000269|PubMed:21242967}. Disease susceptibility is associated with variations affecting the gene represented in this entry.; The ALK signaling pathway plays an important role in glioblastoma, the most common malignant brain tumor of adults and one of the most lethal cancers. It regulates both glioblastoma migration and growth.; A chromosomal aberration involving ALK is found in one subject with colorectal cancer. Translocation t(2;2)(p23.1;p23.3). A 5 million base pair tandem duplication generates an in-frame WDCP-ALK gene fusion. {ECO:0000269|PubMed:22327622}.
General Description of Anaplastic Lymphoma Kinase .
Anaplastic lymphoma kinase (ALK) known as ALK tyrosine kinase receptor or CD246, is a tyrosine kinase receptor. ALK is an important biomarker for diagnosis of non-­‐small cell lung cancer (NSCLC).

Antibody (Suitable for clinical applications)

Sample Type: FFPE Patient Samples.
Tested Applications: IHC. Approved for In Vitro Diagnostic Procedures on FFPE tissues. For tissue collection recommendations, please see datasheet sent with product.
Application Notes
Specification Recommendation
Recommended Dilution (Conc) 1:50-1:100
Pretreatment Citrate Buffer pH 6.0
Incubation Parameters 30 min at Room Temperature

Prior to use, inspect vial for the presence of any precipitate or other unusual physical properties. These can indicate that the antibody has degraded and is no longer suitable for patient samples. Please run positive and negative controls simultaneously with all patient samples to account and control for errors in laboratory procedure. Use of methods or materials not recommended by enQuire Bio including change to dilution range and detection system should be routinely validated by the user.

Clonality: Monoclonal
Anti-Anaplastic Lymphoma Kinase Antibody Clone: 4A4
Host and Isotype: Mouse IgG2b
Recommended Positive Control Sample: Anaplastic large cell lymphoma
Cellular Localization of Antibody 4A4 Staining: Cytoplasmic and nuclear staining
Buffer and Stabilizer: PBS with 1% BSA and 0.05% NaN3
Antibody Concentration: Lot specific. Plese contact tech support for data.
Immunogen: Recombinant human ALK protein fragment.
Storage Conditions: This antibody should be stored refrigerated (2-8°C). This product should not be used past the expiration date printed on the vial.

Anaplastic Lymphoma Kinase Information for Pathologists

Summary:

See also NPM-ALK fusion protein. Anaplastic lymphoma kinase gene is at 2p23; protein is called ALK1, CD246. Membrane spanning tyrosine kinase receptor, member of insulin receptor family. Is NOT the same as Ki-1/CD30, contrary to some references. Interpretation: usually cytoplasmic and nuclear staining.

Limitations and Warranty

This antibody is manufactured in accordance with clinical good manufacturing practices in an ISO13485:2016 certified production facility. It is intended for multiple uses including in vitro diagnostic use and research use only applications. Please see vial label for expiration date. We strive to always deliver antibodies with a shelf life of at least two years.

There are no reviews yet.

Be the first to review “Anaplastic Lymphoma Kinase [4A4] Antibody (cGMP).”

Your email address will not be published. Required fields are marked *

Share a Protocol (View Reviewed Protocols Below)

Protocol Title

Materials

Methods

Notes


  protocol submission gif
enQuire Bio, LLC   8420 S Continental Divide Rd, #202   Littleton, CO 80127
Phone: 1-855-344-1400 | enquire@enquirebio.com | Fax: 1-720-897-3730
Customer Service Available M-F 8AM-6PM MST or 24/7 Via Email

Anaplastic Lymphoma Kinase [4A4] Antibody (cGMP).